BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
Open | $0.54 |
Close | $0.53 |
Volume / Avg. | 299.44K / 384.79K |
Day Range | 0.51 - 0.56 |
52 Wk Range | 0.52 - 2.53 |
Market Cap | $44.77M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), vTv Therapeutics (NASDAQ:VTVT) and Ocean Biomedical (NASDAQ:OCEA).
There is no analysis for BioLine Rx.
BioLine Rx has a consensus price target of $12.50.
The stock price for BioLine Rx (NASDAQ: BLRX) is $0.56 last updated July 3, 2024 at 2:34 PM EDT.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q2 earnings are confirmed for Wednesday, August 28, 2024.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.